NSAIDS - Non-steroidal anti-inflammatory drugs. Flashcards

1
Q

What are Eicosanoids?

A

Local hormones derived upon request from arachidonic acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Arachidonic acid?

A

a constituent

of the membrane phospholipids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is AA released?

A
AA is released by the direct action of
phospholipase A2
.
AA is metabolized to give rise to
eicosanoids:
  • Prostanoids (prostaglandins and thromboxanes)
  • Leucotrienes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are prostanoids?

A

Prostanoids (prostaglandins and
thromboxanes)

They are produced by cyclooxygenase (COX).

There are two forms of COX:
◦ COX-1: constitutive enzyme, involved in tissue homeostasis
◦ COX-2: induced in inflammatory cells by inflammatory stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two forms of COX?

A

There are two forms of COX:
◦ COX-1: constitutive enzyme, involved in tissue homeostasis
◦ COX-2: induced in inflammatory cells by an inflammatory stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Prostacyclin (PGl2)?

A

Prostanoid

predominantly
from vascular endothelium

◦ Vasodilation
◦ Inhibition of platelet aggregation
◦ Sensitization of nerve pain terminals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is thromboxane A2 (TXA2)?

A

Prostanoid

predominantly from platelets
◦ Platelet aggregation
◦ Vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Prostaglandin E1

(PGE1) и E2 (PGE2)?

A

Prostanoid

◦ Mediators of inflammation and fever
◦ Inhibition of gastric acid secretion
◦ Contraction of pregnant uterus and GI smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Prostaglandin F2α

(PGF2α)?

A

◦ Contraction of the uterus

◦ Contraction of vascular and non-vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical uses of prostaglandins in obstetrics?

A

In obstetrics

◦ For induction of labor: Dinoprostone (PGE2) (vaginally in the form of a gel or controlled-release formulation)
◦ For termination of pregnancy: Carboprost (PgF2α)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical uses of prostaglandins in the gastrointestinal tract?

A

◦ To prevent peptic ulcers in patients taking NSAIDs: Misoprostol (PGE1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical uses of prostaglandins in ophthalmology?

A

◦ Open-angle glaucoma: latanoprost, etc. as eye drops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which prostanoids are used in cardiology?

A

◦ Аlprostadil (PGE1)

◦ Iloprost (PGI2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are leukotrienes?

A

5-lipoxygenase acts on arachidonate to give 5-hydroxyperoxyeicosatetraenoic acid (5-HPETE),
which is converted to leucotriene
LTA4

LTA4
in turn can be converted to:
◦ LTB4
◦ Series of cysteinyl-LTs (LTC4, LTD4, LTE4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does LTB4 do?

A

LTB4 acting on specific receptors:

◦ Causes adherence, chemotaxis and activation of polymorphs and
monocytes
◦ Is important mediator in all types of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do the cysteinyl-LTs act on and what do they cause?

A

CysLT1 and CysLT2
receptors

◦ Cause contraction of the bronchial muscle
◦ Are of particular importance in asthma

Anti-leucotriene drugs:
◦ Cys-LT1
receptor antagonists: Мontelucast (used in asthma)

17
Q

How are the NSAIDs classified?

A

I. Non-selective COX-inhibitors

II. Relatively selective COX-2 inhibitors

III. Selective COX-2 inhibitors (coxibs)

18
Q

How are the Non-selective COX-inhibitors classified?

A
  1. Salicylic acid derivatives
  2. Acetic acid derivatives
  3. Enolic acid derivatives (oxicams)
  4. Propionic acid derivatives
19
Q

What is the PK of NSAIDs?

A

NSAIDs are weak acids:
• Well absorbed orally
Highly bound (98%) to plasma
proteins

• They can displace other drugs
Metabolism – CYP, conjugation
reactions

Excretion:
• Predominantly renal
• In the bile (enterohepatic circulation)

20
Q

What are the PDs of NSAIDs?

A

Anti-inflammatory effect: mainly in the acute phase of
inflammation, due to inhibiting PG-dependent
symptoms:
◦ Vasodilation
◦ Edema
◦ Pain

Antipyretic effect: action in the hypothalamus

Analgesic effect: NSAIDs reduce pain in inflammation
owing to decreased sensitization of nociceptive nerve terminals to substances such as bradykinin or
serotonin

21
Q

What are the adverse reactions of NSAIDs?

A

◦ Gastrointestinal: Abdominal pain, nausea,
vomiting, and rarely, ulcers or bleeding;

◦ Renal: Renal insufficiency, renal failure,
hyperkalemia, and proteinuria;

◦ Cardiovascular: Fluid retention,
hypertension, edema, and rarely, myocardial
infarction and congestive heart failure (CHF);

◦ Hepatic: Abnormal liver function test results
and rare liver failure (especially
Nimesulide);

◦ Hematologic: Rare thrombocytopenia,
neutropenia, or even aplastic anemia;

◦ Pulmonary: Asthma (aspirin-sensitive
asthma);

◦ Skin: Rashes, pruritus;

◦ Central nervous system: Headaches,
tinnitus, dizziness.

22
Q

What are the clinical uses of NSAIDs?

A
As analgesics (headache, dysmenorrhea, pain in the
spine, bone metastases, postoperative pain)

As anti-inflammatory drugs in rheumatoid diseases
(acute gout, osteoarthritis, ankylosing spondylitis,
rheumatoid arthritis, inflammation of soft tissues)

As antipyretics: ASA, Ibuprofen
◦ ASA be avoided in children with viral infections (Reye
syndrome)

ASA (low doses: 75-100 mg) – antiplatelet effect –
for prevention and treatment of myocardial
infarction

23
Q

What are selective COX-2 inhibitors?

A

As anti-inflammatory drugs – equally effective
with the non-selective COX-inhibitors

The gastrointestinal ADRs are reduced, but not
the renal.

They have no effect on platelets but inhibit the
synthesis of PGI2
, resulting in an increased incidence
of acute thrombotic events (AMI, stroke).